Evidence map›Paper›PMID 39110391›Full record

ReviewMolecular neurobiology2025

Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders.

Olayemi K Ijomone, Rademene Sunday Oria, Omamuyovwi M Ijomone, Michael Aschner, Julia Bornhorst

Abstract readReview
In one paragraph

Review in Molecular neurobiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Long-term effects of adolescent risperidone treatment on the mouse cortex.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olayemi K IjomoneFood Chemistry, Faculty of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany. oolaibi@unimed.edu.ng.ORCID http://orcid.org/0000-0003-4430-6530
Rademene Sunday OriaDepartment of Anatomy, University of Cross River State, Okuku Campus, Cross River, Nigeria.
Omamuyovwi M IjomoneLaboratory for Experimental and Translational Neurobiology, University of Medical Sciences, Laje Road, Ondo, Ondo State, Nigeria. omijomone@unimed.edu.ng.ORCID http://orcid.org/0000-0002-0933-8409
Michael AschnerDepartment of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, NY, USA.
Julia BornhorstFood Chemistry, Faculty of Mathematics and Natural Science, University of Wuppertal, Wuppertal, Germany.

Funding

Developmental neurotoxicity and autism spectrum disorderK43TW011920 · FIC · UNIVERSITY OF MEDICAL SCIENCES, ONDO · PI Omamuyovwi Meashack Ijomone · 2022 to 2026
$500k
Alexander von Humboldt-Stiftung NGA- 437 1218847-GF-PFIC NIH HHS K43 TW011920NIH HHS 7K43TW011920
6 · The paper itself

Abstract

Brain development may be influenced by both genetic and environmental factors, with potential consequences that may last through the lifespan. Alterations during neurogenesis are linked to neurodevelopmental cognitive disorders. Many neurotransmitters and their systems play a vital role in brain development, as most are present prior to synaptogenesis, and they are involved in the aetiology of many neurodevelopmental disorders. For instance, dopamine (DA) receptor expression begins at the early stages of development and matures at adolescence. The long maturation period suggests how important it is for the stabilisation and integration of neural circuits. DA and dopaminergic (DAergic) system perturbations have been implicated in the pathogenesis of several neurological and neuropsychiatric disorders. The DAergic system controls key cognitive and behavioural skills including emotional and motivated behaviour through DA as a neurotransmitter and through the DA neuron projections to major parts of the brain. In this review, we summarise the current understanding of the DAergic system's influence on neurodevelopment and its involvement in the aetiology and progression of major disorders of the developing brain including autism, schizophrenia, attention deficit hyperactivity disorder, down syndrome, and fragile X syndrome.

Indexed as

DopamineDopaminergic NeuronsNeurodevelopmental DisordersAnimalsBrainHumansDopamineADHDASDDopamineDopaminergic systemFragile XSCZ

Identifiers

PMID39110391
PMCPMC11772124

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.